October 30, 2019 / 6:22 AM / 16 days ago

BRIEF-Roche: FDA Accepts Genentech's Biologics License Application For Satralizumab

Oct 30 (Reuters) - Roche Holding Ag:

* FDA ACCEPTS GENENTECH’S BIOLOGICS LICENSE APPLICATION FOR SATRALIZUMAB FOR NEUROMYELITIS OPTICA SPECTRUM DISORDE Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below